Drug intelligence / Profile preview

Dimuningshen Koufuye

Development stage
Unknown
Lead developer
Lunan Houpu Pharmaceutical
Administration
Oral
01

Overview

Dimuningshen Koufuye is a Traditional Chinese Medicine (TCM) oral liquid formulation primarily indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and tic disorders in children and adolescents. The formulation is composed of several botanical and animal-derived ingredients, including *Rehmannia glutinosa* (Di Huang), *Ostrea gigas* (Mu Li), *Alisma plantago-aquatica* (Ze Xie), *Schisandra chinensis* (Wu Wei Zi), *Scrophularia ningpoensis* (Xuan Shen), and *Scutellaria baicalensis* (Huang Qin). In the context of TCM theory, it is designed to nourish liver and kidney yin, suppress hyperactive liver yang, and calm the spirit (Ning Shen). Clinical research, including studies conducted at Beijing Anding Hospital, has evaluated its efficacy as both a monotherapy and an adjunctive treatment alongside conventional stimulants like methylphenidate or non-stimulants like atomoxetine. Pharmacologically, it is believed to modulate the balance of neurotransmitters in the central nervous system, specifically targeting the dopaminergic and noradrenergic systems to improve attention and reduce hyperactivity.

Brand names
Dimuningshen Koufuye
Other names
Dimuningshen Oral LiquidDi Mu Ning Shen Kou Fu Ye地牡宁神口服液

Beyond the preview

Go deeper on Dimuningshen Koufuye.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dimuningshen Koufuye.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call